Regulatory T cells, a potent immunoregulatory target for CAM researchers: The ultimate antagonist (I)

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 1, 2006, Pages 25-30

  Vojdani, Aristo ^a   Erde, Jonathan ^a  

^a California   (United States)

Author keywords

Immune system modulation; Regulatory T cells; Treg

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BOSWELLIC ACID; BROMELAIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FISH OIL; GINKGO BILOBA EXTRACT; PHYTOSTEROL; RESVERATROL; ROYAL JELLY; TINOSPORA CORDIFOLIA EXTRACT; UNCARIA TOMENTOSA EXTRACT;

AGARICUS BLAZEI; ALLERGY; ALTERNATIVE MEDICINE; AUTOIMMUNITY; CANCER; EVIDENCE BASED MEDICINE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TINOSPORA; TINOSPORA CORDIFOLIA;

EID: 33745698831     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nek022     Document Type: Review

References (60)

1. Bellavite P, Conforti A, Piasere V, Ortolani R. Immunology and homeopathy. 1. Historical background. Evid Based Complement Alternat Med 2005;2:441-52.
2. Lindequist U, Niedermeyer THJ, Jülich W. The Pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2005;2:285-99.
3. Inagaki N, Shibata T, Itoh T, Suzuki T, Tanaka H, Nakamura T, et al. Inhibition of IgE-dependent mouse triphasic cutaneous reaction by a boiling water fraction separated from mycelium of Phellinus linteus. Evid Based Complement Alternat Med 2005;2:369-74.
4. Naser B, Bodinet C, Tegtmeier M, Lindequist U. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. Evid Based Complement Alternat Med 2005;2:69-78.
5. Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid Based Complement Alternat Med 2005;2:99-105.
6. Kaminogawa S, Nanno M. Modulation of immune functions by foods. Evid Based Complement Alternat Med 2004;1:241-50.
7. Coelho MG, Sabino KC, Dalmau SR. Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis. Clin Exp Rheumatol 2004;22:213-8.
8. Bouic PJ. Sterols and sterolins: new drugs for the immune system? Drug Discov Today 2002;7:775-8.
9. Kasai H, He LM, Kawamura M, Yang PT, Deng XW, Munkanta M, et al. IL-12 production induced by Agaricus blazei fraction H (ABH) involves toll-like receptor (TLR). Evid Based Complement Alternat Med 2004;1:259-67.
10. Nair PK, Rodriguez S, Ramachandran R, Alamo A, Melnick SJ, Escalon E, et al. Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia. Int Immunopharmacol 2004;4:1645-59.
11. Haddad PS, Azar GA, Groom S, Boivin M. Natural health products, modulation of immune function and prevention of chronic diseases. Evid Based Complement Alternat Med 2005;2:513-20.
12. Prescott SM, Stenson WF. Fish oil fix. Nat Med 2005;11:596-8.
13. Babcock TA, Novak T, Ong E, Jho DH, Helton WS, Espat NJ. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res 2002;107:135-9.
14. Natarajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through janus kinase-stat pathway in T lymphocytes. J Immunol 2002;169:6506-13.
15. Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-κB as potential targets. J Immunol 2005;174:8116-24.
16. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glöckner-Pagel J, et al. Curcumin, a major constituent of tumeric, corrects cystic fibrosis defects. Science 2004;304:600-2.
17. Mynott TL, Ladhams A, Scarmato P, Engwerda CR. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J Immunol 1999;163:2568-75.
18. Targoni OS, Tary-Lehmann M, Lehmann PV. Prevention of murine EAE by oral hydrolytic enzyme treatment. J Autoimmun 1999;12:191-8.
19. Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, Beutelspacher SC, et al. Inhibition of NF-κB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 2005; 174:7633-44.
20. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, et al. Resveratrol blocks interleukin-1 B-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102:987-95.
21. Kohno K. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 2004;68:138-45.
22. Fujik H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, et al. A new concept of tumor promotion by tumor necrosis factor-α, and cancer preventive agents (-)-epihallocatechin gallate and green tea - a review. Cancer Detect Prev 2000;24:91-9.
23. Syrovets T, Büchele B, Krauss C, Laumonnier Y, Simmet T. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-α induction in monocytes by direct interaction with IκB kinases. J Immunol 2005;174:498-506.
24. Blackwell TS, Blackwell TR, Holden EP, Christman BW. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 1996;157:1630-7.
25. Seya T, Akazawa T, Tsujita T, Matsumoto M. Role of TOLL-like receptors in adjuvant-augmented immune therapies. Evid Based Complement Alternat Med. 2006;3:31-8.
26. Cooper EL. Commentary on role of TOLL-like receptors in adjuvant-augmented immune therapies by T. Seya. Evid Based Complement Alternat Med. 2006;3:133-7.
27. Kulkarni AB, Huh C, Becker D, Geiser A, Lyght M, Flanders KC, et al. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;93:770-4.
28. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30:1538-43.
29. Schwartz RH. Natural regulatory T cells and self-tolerance. Nat Immunol 2005;36:327-30.
30. + immunoregulatory cells. J Immunol 2002;3:135-42.
31. Morelli AE, Thompson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003;196:125-46.
32. Mossman TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
33. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256.
34. + T-cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol Rev 1991;123:23.
35. Del Prete GF, De Carli M, Almerigogna F, Giudizi MC, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-60.
36. Mossman TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111-47.
37. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93:768-5.
38. Swain SL, Bradley LM, Croft M, Tonkonogy S, Atkins G, Weinberg AD, et al. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 1991;123:115-44.
39. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains. J Immunol 1995;155:1151-64.
40. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000;18:423-49.
41. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2001;101:455-8.
42. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
43. Essence of harmony. Nat Immunol 2005; 6:325.
44. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
45. Fonteno JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-7.
46. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
47. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
48. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-α and IL-10 induce the differentiation of human type 1 regulatory T cells. J Immunol 2001;166:5530-9.
49. + T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells. J Exp Med 2000;192:1213-22.
50. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T-cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193:233-8.
51. + regulatory T cells from human peripheral blood. J Immunol 2001;166:7282-9.
52. Godfrey RC. Asthma and IgE levels in rural and urban communities of the Gambia. Clin Allergy 1975;5:201-7.
53. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989;299:1259-60.
54. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-77.
55. McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002;109:43-50.
56. Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M, et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to etopy and allergic asthma: epidemiological study. Br Med J 2000;320:412-7.
57. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease; revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
58. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
59. Smit JJ, Folkerts G, Nijkamp FP. Ramp-ing up allergies: Nramp1 (Slc11a1), macrophages and the hygiene hypothesis. Trends Immunol 2004;25:342-7.
60. Ventura C. CAM and cell fate targeting: molecular and energetic insights into cell growth and differentiation. Evid Based Complement Alternat Med 2005;2:277-83.